Overview

Study of Intra-articular Allocetra in Knee Osteoarthritis

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This is a double blind, randomized,multi-center study to evaluate the safety and efficacy of intra-articular administration of Allocetra compared to placebo in patients with symptomatic knee osteoarthritis.
Phase:
PHASE1
Details
Lead Sponsor:
Enlivex Therapeutics Ltd.
Collaborator:
Nordic Bioscience Clinical Development (NBCD)